Vaxart Historical Income Statement
| VXRT Stock | USD 0.60 0.01 1.64% |
Historical analysis of Vaxart income statement accounts such as Depreciation And Amortization of 9.1 M, Interest Expense of 1.4 M, Total Revenue of 7 M or Other Operating Expenses of 75.8 M can show how well Vaxart Inc performed in making a profits. Evaluating Vaxart income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Vaxart's future profits or losses.
Financial Statement Analysis is much more than just reviewing and examining Vaxart Inc latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Vaxart Inc is a good buy for the upcoming year.
Vaxart |
About Vaxart Income Statement Analysis
Vaxart Inc Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Vaxart shareholders. The income statement also shows Vaxart investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).
Vaxart Income Statement Chart
Add Fundamental
Total Revenue
Total revenue comprises all receipts Vaxart Inc generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.Other Operating Expenses
Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Vaxart Inc. It is also known as Vaxart overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.Cost Of Revenue
Cost of Revenue is found on Vaxart Inc income statement and represents the costs associated with goods and services Vaxart provides. Indirect cost, such as salaries, is not included. In other words, cost of revenue is the total cost incurred to obtain a sale. It is more than the traditional cost of goods sold, since it includes specific selling and marketing activities.Total Operating Expenses
The total costs associated with the day-to-day operations of a business, excluding the cost of goods sold but including selling, general, and administrative expenses.Most accounts from Vaxart's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Vaxart Inc current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Vaxart Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. At this time, Vaxart's Depreciation And Amortization is comparatively stable compared to the past year. Total Operating Expenses is likely to gain to about 95.3 M in 2024, despite the fact that Gross Profit is likely to grow to (57.7 M).
| 2021 | 2022 | 2023 | 2024 (projected) | Total Operating Expenses | 70.6M | 110.4M | 90.7M | 95.3M | Cost Of Revenue | 48.7M | 3.3M | 68.1M | 53.4M |
Vaxart income statement Correlations
Click cells to compare fundamentals
Vaxart Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Vaxart income statement Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Depreciation And Amortization | 3.6M | 1.8M | 2.4M | 3.3M | 8.6M | 9.1M | |
| Interest Expense | 2.4M | 1.9M | 1.5M | 1.3M | 1.4M | 1.4M | |
| Total Revenue | 9.9M | 4.0M | 892K | 107K | 7.4M | 7.0M | |
| Gross Profit | (4.7M) | (15.8M) | (47.9M) | (3.2M) | (60.8M) | (57.7M) | |
| Other Operating Expenses | 20.7M | 35.1M | 70.6M | 110.4M | 90.7M | 75.8M | |
| Operating Income | (15.8M) | (30.2M) | (72.8M) | (114.6M) | (83.3M) | (79.2M) | |
| Ebit | (10.7M) | (30.1M) | (68.9M) | (106.4M) | (83.3M) | (79.2M) | |
| Ebitda | (7.1M) | (28.3M) | (66.5M) | (103.1M) | (74.7M) | (71.0M) | |
| Cost Of Revenue | 14.5M | 19.9M | 48.7M | 3.3M | 68.1M | 53.4M | |
| Total Operating Expenses | 20.7M | 35.1M | 70.6M | 110.4M | 90.7M | 95.3M | |
| Income Before Tax | (18.2M) | (32.0M) | (70.4M) | (107.7M) | (82.2M) | (78.1M) | |
| Total Other Income Expense Net | (5.1M) | (1.8M) | 2.4M | 6.9M | 1.1M | 1.0M | |
| Net Income | (18.6M) | (32.2M) | (70.5M) | (107.8M) | (82.5M) | (78.3M) | |
| Income Tax Expense | 490K | 238K | 107K | 67K | 261K | 440.2K | |
| Selling General Administrative | 6.2M | 15.2M | 21.9M | 29.4M | 22.6M | 21.2M | |
| Research Development | 14.5M | 19.9M | 48.7M | 81.1M | 68.1M | 71.5M | |
| Net Income From Continuing Ops | (18.6M) | (32.2M) | (70.5M) | (107.8M) | (82.5M) | (78.3M) | |
| Non Operating Income Net Other | (2.2M) | (13K) | (1K) | (6K) | (5.4K) | (5.1K) | |
| Net Income Applicable To Common Shares | (18.6M) | (32.2M) | (70.5M) | (107.8M) | (97.0M) | (92.1M) | |
| Tax Provision | 490K | 238K | 107K | 67K | 261K | 216.2K | |
| Net Interest Income | (2.2M) | (1.8M) | (1.4M) | (58K) | 1.2M | 1.3M | |
| Interest Income | 149K | 75K | 81K | 1.2M | 2.7M | 2.8M | |
| Reconciled Depreciation | 3.6M | 2.7M | 4.2M | 5.8M | 8.6M | 4.4M |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Vaxart Stock Analysis
When running Vaxart's price analysis, check to measure Vaxart's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vaxart is operating at the current time. Most of Vaxart's value examination focuses on studying past and present price action to predict the probability of Vaxart's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vaxart's price. Additionally, you may evaluate how the addition of Vaxart to your portfolios can decrease your overall portfolio volatility.